These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of long-term chloroquine administration on the natural history of aortic aneurysms in mice. Ramadan A; Wheatcroft MD; Quan A; Singh KK; Lovren F; Dhingra N; Teoh H; Al-Omran M; Leong-Poi H; Verma S Can J Physiol Pharmacol; 2015 Aug; 93(8):641-8. PubMed ID: 26099030 [TBL] [Abstract][Full Text] [Related]
9. The effects of angiotensin II on the coupled microstructural and biomechanical response of C57BL/6 mouse aorta. Haskett D; Speicher E; Fouts M; Larson D; Azhar M; Utzinger U; Vande Geest J J Biomech; 2012 Mar; 45(5):772-9. PubMed ID: 22196971 [TBL] [Abstract][Full Text] [Related]
10. Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Gavrila D; Li WG; McCormick ML; Thomas M; Daugherty A; Cassis LA; Miller FJ; Oberley LW; Dellsperger KC; Weintraub NL Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1671-7. PubMed ID: 15933246 [TBL] [Abstract][Full Text] [Related]
11. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse. Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772 [TBL] [Abstract][Full Text] [Related]
12. Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice. Inoue N; Muramatsu M; Jin D; Takai S; Hayashi T; Katayama H; Kitaura Y; Tamai H; Miyazaki M Atherosclerosis; 2009 Jun; 204(2):359-64. PubMed ID: 18996524 [TBL] [Abstract][Full Text] [Related]
13. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. Moran CS; Rush CM; Dougan T; Jose RJ; Biros E; Norman PE; Gera L; Golledge J Arterioscler Thromb Vasc Biol; 2016 May; 36(5):898-907. PubMed ID: 26966276 [TBL] [Abstract][Full Text] [Related]
14. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes. Moran CS; Jose RJ; Moxon JV; Roomberg A; Norman PE; Rush C; Körner H; Golledge J Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):814-21. PubMed ID: 23393391 [TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880 [TBL] [Abstract][Full Text] [Related]
16. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Yamanouchi D; Morgan S; Kato K; Lengfeld J; Zhang F; Liu B Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):702-7. PubMed ID: 20075419 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137 [TBL] [Abstract][Full Text] [Related]